Literature DB >> 22031947

Characterization, mapping, and distribution of the two XMRV parental proviruses.

Oya Cingöz1, Tobias Paprotka, Krista A Delviks-Frankenberry, Sheryl Wildt, Wei-Shau Hu, Vinay K Pathak, John M Coffin.   

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) was previously reported to be associated with human prostate cancer and chronic fatigue syndrome. Our groups recently showed that XMRV was created through recombination between two endogenous murine retroviruses, PreXMRV-1 and PreXMRV-2, during the passaging of a prostate tumor xenograft in nude mice. Here, multiple approaches that led to the identification of PreXMRV-2, as well as the distribution of both parental proviruses among different mouse species, are described. The chromosomal loci of both proviruses were determined in the mouse genome, and integration site information was used to analyze the distribution of both proviruses in 48 laboratory mouse strains and 46 wild-derived strains. The strain distributions of PreXMRV-1 and PreXMRV-2 are quite different, the former being found predominantly in Asian mice and the latter in European mice, making it unlikely that the two XMRV ancestors could have recombined independently in the wild to generate an infectious virus. XMRV was not present in any of the mouse strains tested, and among the wild-derived mouse strains analyzed, not a single mouse carried both parental proviruses. Interestingly, PreXMRV-1 and PreXMRV-2 were found together in three laboratory strains, Hsd nude, NU/NU, and C57BR/cd, consistent with previous data that the recombination event that led to the generation of XMRV could have occurred only in the laboratory. The three laboratory strains carried the Xpr1(n) receptor variant nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that the xenografted human tumor cells were required for the resulting XMRV recombinant to infect and propagate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031947      PMCID: PMC3255884          DOI: 10.1128/JVI.06022-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  65 in total

1.  The natural history and immunopathology of outbred athymic (nude) mice.

Authors:  M E Gershwin; B Merchant; M C Gelfand; J Vickers; A D Steinberg; C T Hansen
Journal:  Clin Immunol Immunopathol       Date:  1975-09

2.  XMRV: a new virus in prostate cancer?

Authors:  Amanda L Aloia; Karen S Sfanos; William B Isaacs; Qizhi Zheng; Frank Maldarelli; Angelo M De Marzo; Alan Rein
Journal:  Cancer Res       Date:  2010-10-21       Impact factor: 12.701

3.  Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome.

Authors:  Harriet C T Groom; Virginie C Boucherit; Kerry Makinson; Edward Randal; Sarah Baptista; Suzanne Hagan; John W Gow; Frank M Mattes; Judith Breuer; Jonathan R Kerr; Jonathan P Stoye; Kate N Bishop
Journal:  Retrovirology       Date:  2010-02-15       Impact factor: 4.602

4.  Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort.

Authors:  Frank J M van Kuppeveld; Arjan S de Jong; Kjerstin H Lanke; Gerald W Verhaegh; Willem J G Melchers; Caroline M A Swanink; Gijs Bleijenberg; Mihai G Netea; Jochem M D Galama; Jos W M van der Meer
Journal:  BMJ       Date:  2010-02-25

5.  Envelope and long terminal repeat sequences of an infectious murine leukemia virus from a human SCLC cell line: implications for gene transfer.

Authors:  M Antoine; B Wegmann; P Kiefer
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 6.  Wild mice: an ever-increasing contribution to a popular mammalian model.

Authors:  Jean Louis Guénet; François Bonhomme
Journal:  Trends Genet       Date:  2003-01       Impact factor: 11.639

7.  Disease-associated XMRV sequences are consistent with laboratory contamination.

Authors:  Stéphane Hué; Eleanor R Gray; Astrid Gall; Aris Katzourakis; Choon Ping Tan; Charlotte J Houldcroft; Stuart McLaren; Deenan Pillay; Andrew Futreal; Jeremy A Garson; Oliver G Pybus; Paul Kellam; Greg J Towers
Journal:  Retrovirology       Date:  2010-12-20       Impact factor: 4.602

8.  Mouse DNA contamination in human tissue tested for XMRV.

Authors:  Mark J Robinson; Otto W Erlwein; Steve Kaye; Jonathan Weber; Oya Cingoz; Anup Patel; Marjorie M Walker; Wun-Jae Kim; Mongkol Uiprasertkul; John M Coffin; Myra O McClure
Journal:  Retrovirology       Date:  2010-12-20       Impact factor: 4.602

9.  No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population.

Authors:  Mark James Robinson; Philip William Tuke; Otto Erlwein; Kate I Tettmar; Steve Kaye; Kikkeri N Naresh; Anup Patel; Marjorie M Walker; Takahiro Kimura; Ganesh Gopalakrishnan; Richard S Tedder; Myra O McClure
Journal:  Adv Virol       Date:  2011-06-09

10.  Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses.

Authors:  Patric Jern; Jonathan P Stoye; John M Coffin
Journal:  PLoS Genet       Date:  2007-09-10       Impact factor: 5.917

View more
  18 in total

1.  Broad-scale phylogenomics provides insights into retrovirus-host evolution.

Authors:  Alexander Hayward; Manfred Grabherr; Patric Jern
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 2.  Recombinant origin, contamination, and de-discovery of XMRV.

Authors:  Krista Delviks-Frankenberry; Oya Cingöz; John M Coffin; Vinay K Pathak
Journal:  Curr Opin Virol       Date:  2012-07-19       Impact factor: 7.090

3.  No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses.

Authors:  Harriet C T Groom; Anne Y Warren; David E Neal; Kate N Bishop
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

4.  Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms.

Authors:  Takayuki Nitta; Sangouk Lee; Dat Ha; Maribel Arias; Christine A Kozak; Hung Fan
Journal:  Retrovirology       Date:  2012-07-24       Impact factor: 4.602

5.  Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail.

Authors:  Marceline Côté; Yi-Min Zheng; Shan-Lu Liu
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

6.  No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer.

Authors:  G Khan; P S Philip; M Naase; K M I Al Zarouni
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640

Review 7.  Origins of the endogenous and infectious laboratory mouse gammaretroviruses.

Authors:  Christine A Kozak
Journal:  Viruses       Date:  2014-12-26       Impact factor: 5.048

Review 8.  Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.

Authors:  Ivana Strazic Geljic; Paola Kucan Brlic; Lucija Musak; Dubravka Karner; Andreja Ambriović-Ristov; Stipan Jonjic; Peter Schu; Tihana Lenac Rovis
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

9.  Cholesterol depletion inactivates XMRV and leads to viral envelope protein release from virions: evidence for role of cholesterol in XMRV infection.

Authors:  Yuyang Tang; Alvin George; Thyneice Taylor; James E K Hildreth
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

10.  Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2.

Authors:  Krista Delviks-Frankenberry; Tobias Paprotka; Oya Cingöz; Sheryl Wildt; Wei-Shau Hu; John M Coffin; Vinay K Pathak
Journal:  J Virol       Date:  2013-08-21       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.